Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000894579-23-000135
Filing Date
2023-03-13
Accepted
2023-03-13 17:12:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G modernatx13g03132023.htm SC 13G 48051
  Complete submission text file 0000894579-23-000135.txt   49718
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87951 | Film No.: 23728188
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-800-4592
ModernaTX, Inc. (Filed by) CIK: 0001962626 (see all company filings)

EIN.: 270226313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G